Ubs Group Ag Apyx Medical Corp Transaction History
Ubs Group Ag
- $555 Billion
- Q2 2025
A detailed history of Ubs Group Ag transactions in Apyx Medical Corp stock. As of the latest transaction made, Ubs Group Ag holds 405 shares of APYX stock, worth $1,166. This represents 0.0% of its overall portfolio holdings.
Number of Shares
405
Previous 4,308
90.6%
Holding current value
$1,166
Previous $5,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding APYX
# of Institutions
48Shares Held
17.6MCall Options Held
50.1KPut Options Held
0-
Nantahala Capital Management, LLC New Canaan, CT3.34MShares$9.61 Million0.33% of portfolio
-
Archon Capital Management LLC Seattle, WA3.28MShares$9.45 Million6.88% of portfolio
-
Royce & Associates LP2.44MShares$7.03 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.48MShares$4.25 Million0.0% of portfolio
-
Silverberg Bernstein Capital Management LLC Armonk, NY987KShares$2.84 Million1.28% of portfolio
About Apyx Medical Corp
- Ticker APYX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 34,573,000
- Market Cap $99.6M
- Description
- Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium to cut, coagulate and ab...